Texas Retina Associates First in U.S. to Dose a Patient in the Phase 2 SIGLEC Trial
On June 1, 2023, Ashkan Abbey, MD, dosed the first patient in the Phase II SIGLEC Trial, a clinical study evaluating AVD-104, a potential new treatment for geographic atrophy (GA) from age-related
read more
Meet Our Plano Clinical Research Coordinators
Tara Keesling and Veronica Bennett are the clinical research coordinators for our Plano office. In addition to enrolling patients in clinical trials for a number of retina conditions like diabetic retinopathy, age-related
read more
Meet Our Fort Worth Clinical Research Coordinators
Lori Hastings and Tina Bell serve as the clinical research coordinators for our Fort Worth office, managing the enrollment and participation of patients in our clinical trials. These studies explore promising new
read more
Meet Our Dallas Clinical Research Coordinators
Karen Duignan, Sally Arceneaux, Ashley Hughes and Jessica Flores serve as our clinical research coordinators for Dallas. They assist patients with their enrollment and participation in our wide variety of clinical trials
read more